Regenerative medicine funding policies in Europe and The Netherlands.

Authors:
de Haan G; de Crom R; Dzierzak E; Mummery C.

Journal:
NPJ Regen Med

Publication Year: 2017

DOI:
10.1038/s41536-016-0006-8

PMCID:
PMC5677946

PMID:
29302338

View on PubMed View on PMC View Publisher
Journal Information

Full Title: NPJ Regen Med

Abbreviation: NPJ Regen Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Biological study of skin wound treated with Alginate/Carboxymethyl cellulose/chorion membrane, diop…
Mahheidari N; Kamalabadi-Farahani M; Nourani MR and 4 more (2024) - Transparency Score: 3/6
Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal…
Ji C; Zhang J; Shi L and 4 more (2024) - Transparency Score: 3/6
hUC-MSCs-derived MFGE8 ameliorates locomotor dysfunction via inhibition of ITGB3/ NF-κB signaling i…
Xu H; Jiang W; Li X and 12 more (2024) - Transparency Score: 4/6
Inflammation-suppressing cornea-in-a-syringe with anti-viral GF19 peptide promotes regeneration in …
Simoliunas E; Ruedas-Torres I; Jiménez-Gómez Y and 18 more (2024) - Transparency Score: 4/6
MSCs mediate long-term efficacy in a Crohn's disease model by sustained anti-inflammatory macrophag…
Dave M; Dev A; Somoza RA and 15 more (2024) - Transparency Score: 5/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing financial interests."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025